Skip to main content

BARCLAYS PLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 312069 LONDON, X0

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
98,327
-47.6% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
1,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 98,327
2025-12-31 187,712
2025-12-31 1,400
2025-09-30 269,527
2025-06-30 273,912
2025-03-31 191,237
2024-12-31 159,565
2024-09-30 255,897
2024-06-30 216,878
2024-03-31 25,792
2023-12-31 196,391
2023-09-30 342,889
2023-09-30 256,400
2023-06-30 312,230
2023-03-31 242,181
2022-12-31 227,347
2022-09-30 133,149
2022-06-30 23,436
2022-03-31 52,604
2021-12-31 145,248
2021-09-30 3,600
2021-09-30 32,693
2021-06-30 37,119
2021-03-31 92,034
2020-12-31 88,630
2020-09-30 160,818
2020-06-30 63,504
2020-03-31 190,038